Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor-Reference-Cited by-同舟云学术

Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor

Published:2000-01 Issue:1 Volume:57 Page:33-40
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Sweeney William E.,Chen Yuegang,Nakanishi Koichi,Frost Philip,Avner Ellis D.

Publisher

Elsevier BV

Subject

Nephrology

Reference37 articles.

1. Autosomal dominant polycystic kidney disease,;Gabow,1990

2. Polycystic kidney disease,;McDonald;Pediatric Nephrology,1999

3. Genetic heterogeneity of polycystic kidney disease in Europe;Peters;Contrib Nephrol,1992

4. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease;Daoust;Genomics,1995

5. The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1-p12: Implications for genetic counseling;Guay-Woodford;Am J Hum Genet,1995

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of EGFR in vascular AT1R signaling: From cellular mechanisms to systemic relevance;Biochemical Pharmacology;2023-11

2. Folate conjugated nanomedicines for selective inhibition of mTOR signaling in polycystic kidneys at clinically relevant doses;Biomaterials;2023-11

3. Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials;Signal Transduction and Targeted Therapy;2023-09-06

4. Renal ciliopathies: promising drug targets and prospects for clinical trials;Expert Opinion on Therapeutic Targets;2023-05-04

5. KLC3 Regulates Ciliary Trafficking and Cyst Progression in CILK1 Deficiency–Related Polycystic Kidney Disease;Journal of the American Society of Nephrology;2022-09